{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:02:48Z","timestamp":1793761368946,"version":"4.6.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["874866"],"award-info":[{"award-number":["874866"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2019127"],"award-info":[{"award-number":["2019127"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2021087"],"award-info":[{"award-number":["2021087"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020046"],"award-info":[{"award-number":["2020046"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["300049"],"award-info":[{"award-number":["300049"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"publisher","award":["287872"],"award-info":[{"award-number":["287872"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2025.102814","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:05:14Z","timestamp":1766765114000},"page":"102814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection"],"prefix":"10.1016","volume":"37","author":[{"given":"Ane Marie","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Tj\u00e4rnhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebla Maria","family":"Hinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranveig","family":"Braathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnveig","family":"Grodeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjarne","family":"Bogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102814_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratory mortality: a modelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102814_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtn.2025.102814_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11684-013-0275-1","article-title":"The first avian influenza A (H7N9) viral infection in humans in Zhejiang Province, China: a death report","volume":"7","author":"Chen","year":"2013","journal-title":"Front. Med."},{"key":"10.1016\/j.omtn.2025.102814_bib4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2414610","article-title":"Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans","volume":"392","author":"Garg","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102814_bib5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(16)00129-8","article-title":"Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies","volume":"16","author":"Belongia","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.omtn.2025.102814_bib6","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.1600893","article-title":"Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination","volume":"197","author":"Grodeland","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib7","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.4049\/jimmunol.1300504","article-title":"DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza","volume":"191","author":"Grodeland","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib8","doi-asserted-by":"crossref","first-page":"e01340-17","DOI":"10.1128\/JVI.01340-17","article-title":"A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza","volume":"91","author":"Andersen","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102814_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/eji.201445080","article-title":"Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus","volume":"45","author":"Fossum","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080008","article-title":"The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype","volume":"8","author":"Gr\u00f8deland","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102814_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110901","article-title":"Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses","volume":"39","author":"Hinke","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2025.102814_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41541-019-0101-0","article-title":"Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules","volume":"4","author":"Andersen","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.omtn.2025.102814_bib13","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.4049\/jimmunol.1701088","article-title":"Simultaneous Targeting of Multiple Hemagglutinins to APCs for Induction of Broad Immunity against Influenza","volume":"200","author":"Anderson","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41467-024-44889-w","article-title":"Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins","volume":"15","author":"Hinke","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102814_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4049\/immunohorizons.1700038","article-title":"The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules","volume":"2","author":"Braathen","year":"2018","journal-title":"Immunohorizons"},{"key":"10.1016\/j.omtn.2025.102814_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.vaccine.2010.10.057","article-title":"Human chemokine MIP1\u03b1 increases efficiency of targeted DNA fusion vaccines","volume":"29","author":"Ruffini","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102814_bib17","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-22-1927","article-title":"A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I\/IIa Trial","volume":"28","author":"Hillemanns","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2025.102814_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010827","article-title":"Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study","volume":"13","author":"Hillemanns","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omtn.2025.102814_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2005.10.019","article-title":"DNA Vaccines Increase Immunogenicity of Idiotypic Tumor Antigen by Targeting Novel Fusion Proteins to Antigen-Presenting Cells","volume":"13","author":"Fredriksen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102814_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.omtm.2020.01.007","article-title":"A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza","volume":"17","author":"Braathen","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102814_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(02)00034-0","article-title":"Stabilization of soluble, low-affinity HLA-DM\/HLA-DR1 complexes by leucine zippers","volume":"263","author":"Busch","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.omtn.2025.102814_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108069","article-title":"DNA Vaccines: MHC II-Targeted Vaccine Protein Produced by Transfected Muscle Fibres Induces a Local Inflammatory Cell Infiltrate in Mice","volume":"9","author":"L\u00f8v\u00e5s","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102814_bib23","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.1014515107","article-title":"Fc\u03b3RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102814_bib24","doi-asserted-by":"crossref","first-page":"13463","DOI":"10.1128\/JVI.05193-11","article-title":"Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies","volume":"85","author":"Terajima","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102814_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","article-title":"Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses","volume":"20","author":"Kanekiyo","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102814_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.omtn.2025.102814_bib28","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1182\/blood-2006-06-032938","article-title":"Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences","volume":"110","author":"Fredriksen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102814_bib29","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.vaccine.2019.11.084","article-title":"Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs","volume":"38","author":"Grodeland","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.omtn.2025.102814_bib30","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc Receptor-Mediated Phagocytosis Makes a Significant Contribution to Clearance of Influenza Virus Infections","volume":"166","author":"Huber","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2025.102814_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"Henry Dunand","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2025.102814_bib33","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102814_bib34","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/JVI.01292-12","article-title":"Unraveling of a Neutralization Mechanism by Two Human Antibodies against Conserved Epitopes in the Globular Head of H5 Hemagglutinin","volume":"87","author":"Qian","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.omtn.2025.102814_bib35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(97)00034-3","article-title":"Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells","volume":"204","author":"Norderhaug","year":"1997","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.omtn.2025.102814_bib37","doi-asserted-by":"crossref","first-page":"W521","DOI":"10.1093\/nar\/gkae241","article-title":"The EMBL-EBI Job Dispatcher sequence analysis tools framework in 2024","volume":"52","author":"Madeira","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102814_bib38","doi-asserted-by":"crossref","first-page":"W465","DOI":"10.1093\/nar\/gkn180","article-title":"Phylogeny.fr: robust phylogenetic analysis for the non-specialist","volume":"36","author":"Dereeper","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102814_bib39","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102814_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747774","article-title":"Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747032","article-title":"Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief","volume":"12","author":"Andersen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2025.102814_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS","volume":"27","author":"REED","year":"1938","journal-title":"Am. J. Epidemiol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:14:51Z","timestamp":1780103691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253125003683"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102814","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccines targeting hemagglutinin from 18 subtypes of influenza A virus to antigen-presenting cells confer broad protection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102814"}}